Medscape

Forest to Discontinue Memantine 5-, 10-mg Tablets

Forest Laboratories announced today that the company will discontinue sale of memantine (Namenda) 5-mg and 10-mg tablets effective August 15, 2014, in favor of focusing on sales of its once-daily ...
Medscape

Memantine: A Treatment for Alzheimer's Disease With a New Formulation

† Adverse events occurring in at least 2% of patients treated with memantine ER and at a rate that is higher than in the placebo group. SIB: significant benefit for memantine (LSMD: 2.6; 95% CI: 1.0–4 ...
Business Wire

Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
FiercePharma

Actavis and Adamas Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride

- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS ...
FierceBiotech

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type NEW YORK, Jun 21, 2010 (BUSINESS WIRE ...
Nature

Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis

Startle was measured as previously described (eg, Swerdlow et al, 2006a; see Supplementary Methods for details of signal acquisition and processing). Broadband noise (70 dB(A)) preceded active stimuli ...
Nature

The Effects of Memantine on Prepulse Inhibition

The methods used in this study were approved by the UCSD Human Subject Institutional Review Board (human studies) or were in accordance with the National Institute of Health Guide for the Care and Use ...
ascopubs.org

Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma.

Association of anticonvulsant prophylaxis in patients with primary and metastatic brain tumors and 1-year overall survival: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from ...
GEN

Actavis-Adamas Alzheimer’s Treatment Wins FDA Nod

Actavis and Adamas Pharmaceuticals said today they won FDA approval for Namzaric, in a rare favorable outcome for treatments indicated for Alzheimer’s disease. Namzaric is indicated for the treatment ...
Healio

Memantine improves social impairment in youths with autism spectrum disorder

Among a small cohort of children and adolescents with autism spectrum disorder, a 12-week course of memantine led to improved ...
FiercePharma

Actavis and Adamas Announce FDA Approval of NamzaricTM, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride

- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS ...